The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a major public health concern in India. This ...

Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.

With vision loss due to diabetes emerging as one of the most serious yet overlooked complications in India, Firstpost brings ...

Diabetes affects more than 101 million people in India today. The number is estimated to reach 125 million by the year 2045.

A study analyzed the geographic and institutional disparities in clinical trial distribution for candidates targeting the ...